JSH BIOTECH ApS: Financial statements 2025
CVR: 25220129
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
JSH BIOTECH ApS (CVR 25220129) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 620,332 and a net result of DKK 3,409,861 compared with DKK 1,154,367 the year before. That is an increase of 219.3% compared with the year before. Equity in the 2025 report amounted to DKK 6,651,503. The solvency ratio was 95%.
- Gross Profit
- DKK 620,332
- Profit/Loss
- DKK 3,409,861
- Equity
- DKK 6,651,503
- Total Assets
- DKK 7,003,192
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 620 t. | 3.4 mio. | 6.7 mio. | - |
| 2024 | - | 194 t. | 1.2 mio. | 3.4 mio. | - |
| 2023 | - | 301 t. | -1.3 mio. | 2.3 mio. | - |
| 2022 | - | 341 t. | -3.3 mio. | 3.8 mio. | - |
| 2021 | - | 649 t. | 3.1 mio. | 7.2 mio. | - |
Official annual report
How creditworthy is JSH BIOTECH ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
JSH BIOTECH ApS has published its annual report for 2024. Gross profit came to DKK 194,261, and the net result was DKK 1,154,367.
About JSH BIOTECH ApS
JSH BIOTECH ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2000. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named VICH 5941 ApS. The management consists of John Sørensen Haurum. The company is owned by John Sørensen Haurum. In 2025, the company reported a gross profit of DKK 620,332 and a net result of DKK 3,409,861 compared with DKK 1,154,367 the year before. Equity in the 2025 report amounted to DKK 6,651,503.